BillionToOne, Inc. Class A
(NASDAQ: BLLN)
BillionToOne, Inc. develops DNA molecular counting technology. It can detect disorders such as sickle cell disease and cystic fibrosis. The company was founded by Oguzhan Atay, Sukrit Silas, and David Tsao and is headquartered in Palo Alto, CA.
104.020
+1.260
(+1.23%)
Range
99.610 - 107.065
(7.48%)
Open
105.000
Previous Close
102.760
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
185,868
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
